Published 05 Jul 2020

FDA clearance gives wings to Indian AI tool for fast diagnosis


Back has obtained US FDA 510(k) clearance for its innovative AI imaging tool, qER, designed to assist emergency room staff in triaging patients based on head CT scans. Qure's product can swiftly detect critical conditions: intracranial bleeds, mass effect, midline shift, and cranial fractures.
In the wake of the COVID-19 pandemic, AI tools like qER are crucial in assisting radiologists working from home—the tool aids in accelerating scan reading and prioritizing critical cases.
Although it took the startup a year and a half to receive FDA clearance, the team at Qure is optimistic that future approvals will be more straightforward due to their established contacts with US hospitals and radiologists.
Sequoia India led a $16 million funding round for Qure earlier this year, affirming the quality and potential of the health tech products being developed in India. Qure, which also has CE certification in Europe, is now deployed in multiple locations worldwide, offering hope for a more effective triaging process in the challenging healthcare landscape.

Share this story